Supplemental Data
Files in this Data Supplement:
- Supplemental Table 1 and Figs. 1-2 (.pdf, 1.2 MB) - Supplemental Table I. DNA oligonucleotide sequences used for cloning and mutagenesis in this study. Supplemental Fig. 1 Quality control of XlyACAT and its gain-of-function mutants. Supplemental Fig. 2 Melting profiles of PlyL provides no evidence for significant interaction between the catalytic domain and CBD.